Who'll brave the pitfalls of generic competition and restless shareholders and pipeline pressure to be the last Big Pharma/Big Biotech CEO standing? That's what the WSJ Health Blog is asking with a new tourney bracket pitting the likes of Pfizer's Jeff Kindler (photo [1]) and Genentech's Arthur Levinson (photo [2]) against one another. Fill in the blanks to reach your own conclusions. Report [3]